Cipla, Jubilant Life, Hetero, Mylan ink licensing pact with Gilead for COVID-19 drug remdesivir
New Delhi: Four domestic pharma firms – Cipla, Jubilant Life Sciences, Hetero and Mylan – have entered into non-exclusive licensing agreements ...
Read more